Michael Kavanaugh

Title: Michael Kavanaugh: Innovator in Synthetic Peptides

Introduction

Michael Kavanaugh is a notable inventor based in Danville, CA (US). He has made significant contributions to the field of synthetic peptides, particularly in relation to FGF receptor affinity. His work has implications for both research and therapeutic applications.

Latest Patents

Kavanaugh holds a patent for "Synthetic peptides having FGF receptor affinity." This patent includes peptidic compositions characterized by having little or no homology to naturally occurring bFGF. The fusion proteins described in the patent include the peptidic composition linked to an oligomerization domain, either directly or through a linking group. Additionally, these compositions may include a heparin binding domain. The applications of these peptidic compositions, fusion proteins, and oligomers are diverse, particularly in contexts where FGF receptor ligands are utilized.

Career Highlights

Michael Kavanaugh has been associated with Chiron Corporation, where he has furthered his research and development efforts. His innovative work in synthetic peptides has positioned him as a key figure in the field.

Collaborations

Kavanaugh has collaborated with various professionals, including his coworker Marcus D Ballinger, to advance his research initiatives.

Conclusion

Michael Kavanaugh's contributions to synthetic peptides and FGF receptor affinity highlight his role as an influential inventor in the biotechnology sector. His patent and ongoing work continue to pave the way for advancements in therapeutic applications.